AARTIDRUGSNSEAarti Drugs Limited· PharmaceuticalsHighNegative
Announced Mon, 6 Jul · 15:04 IST

Promoter group members report encumbrance of 12.39 lakh shares

Ownership Changes View source PDF

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹386.25
prior close
₹379.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.0+0.2+0.7+1.0+3.0+3.0+2.4+9.3+6.1
Up moveDown movePending
AI summary

Harshit M. Savla, promoter of Aarti Drugs, filed an annual declaration under SEBI Takeover Regulations on April 9, 2026. Two promoter group members - Mirik Rajendra Gogri and Renil Rajendra Gogri - have encumbered 6.41 lakh and 5.98 lakh shares respectively as on March 31, 2026, totaling about 12.39 lakh shares. No other encumbrance was created by the promoter group during FY26.

Likely market impact

Routine annual disclosure of existing share encumbrance by two promoter group entities. No new pledging activity reported during the year.